Latest news
RYTM Maintained by JP Morgan -- Price Target Raised to $146 - GuruFocusGuruFocus · Fri, 07 Aug 2026 19:17:20 GMTRYTM Maintained by Citigroup -- Price Target Raised to $143.00 - GuruFocusGuruFocus · Thu, 06 Aug 2026 00:19:50 GMTRYTM Maintained by RBC Capital -- Price Target Raised to $155 - GuruFocusGuruFocus · Wed, 05 Aug 2026 19:40:59 GMTIs Rhythm Pharmaceuticals Inc (RYTM) Undervalued After Q2 Earnin - GuruFocusGuruFocus · Tue, 04 Aug 2026 12:52:05 GMTRYTM Looks 10.9% Undervalued on GF Value™ Amid Mixed Guru and In - GuruFocusGuruFocus · Tue, 04 Aug 2026 12:11:26 GMTQ2 2026 Rhythm Pharmaceuticals Inc Earnings Call Transcript - GuruFocusGuruFocus · Tue, 04 Aug 2026 12:00:00 GMTBSX Maintained by Oppenheimer -- Price Target Lowered to $85.00 - GuruFocusGuruFocus · Mon, 27 Jul 2026 15:56:57 GMT